Pinnacle Associates Ltd. Sells 7,042 Shares of Itron, Inc. $ITRI

Pinnacle Associates Ltd. reduced its stake in Itron, Inc. (NASDAQ:ITRI) by 3.0% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 226,764 shares of the scientific and technical instruments company’s stock after selling 7,042 shares during the period. Pinnacle Associates Ltd.’s holdings in Itron were worth $21,057,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of ITRI. Private Trust Co. NA raised its stake in Itron by 112.4% in the fourth quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company’s stock worth $25,000 after buying an additional 145 shares in the last quarter. Employees Retirement System of Texas bought a new position in Itron in the third quarter worth about $32,000. Optiver Holding B.V. bought a new position in Itron in the third quarter worth about $36,000. Aster Capital Management DIFC Ltd bought a new position in Itron in the third quarter worth about $44,000. Finally, Northwestern Mutual Wealth Management Co. raised its stake in Itron by 343.6% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company’s stock worth $46,000 after buying an additional 268 shares in the last quarter. 96.19% of the stock is owned by institutional investors.

Insider Activity

In other news, CAO David Marshall Wright sold 264 shares of the stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $100.17, for a total transaction of $26,444.88. Following the sale, the chief accounting officer owned 9,124 shares in the company, valued at $913,951.08. This represents a 2.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Laurie Ann Pulatie-Hahn sold 729 shares of the stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $100.17, for a total transaction of $73,023.93. Following the sale, the senior vice president owned 32,950 shares in the company, valued at approximately $3,300,601.50. The trade was a 2.16% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 51,162 shares of company stock valued at $5,080,646. Company insiders own 1.77% of the company’s stock.

Itron Price Performance

Shares of ITRI opened at $82.22 on Thursday. The stock has a market cap of $3.65 billion, a PE ratio of 13.11, a price-to-earnings-growth ratio of 0.71 and a beta of 1.35. The company has a debt-to-equity ratio of 0.97, a quick ratio of 2.24 and a current ratio of 2.66. Itron, Inc. has a fifty-two week low of $78.53 and a fifty-two week high of $142.00. The firm’s 50-day simple moving average is $90.13 and its two-hundred day simple moving average is $96.51.

Itron (NASDAQ:ITRI) last announced its quarterly earnings data on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.23. The business had revenue of $586.98 million for the quarter, compared to analysts’ expectations of $572.04 million. Itron had a net margin of 12.31% and a return on equity of 19.54%. The business’s revenue was down 3.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.52 earnings per share. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. Analysts anticipate that Itron, Inc. will post 6.01 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on ITRI. Robert W. Baird set a $128.00 price target on shares of Itron and gave the stock an “outperform” rating in a research note on Wednesday, February 18th. Raymond James Financial began coverage on shares of Itron in a report on Tuesday, April 21st. They issued an “underperform” rating on the stock. Guggenheim set a $155.00 price objective on shares of Itron in a report on Friday, February 13th. Needham & Company LLC began coverage on shares of Itron in a report on Friday, March 6th. They issued a “buy” rating and a $124.00 price objective on the stock. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Itron in a report on Friday, May 8th. Eight analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $131.22.

Itron Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.